Andreas M. Hohlbaum

2.9k total citations · 1 hit paper
25 papers, 2.4k citations indexed

About

Andreas M. Hohlbaum is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andreas M. Hohlbaum has authored 25 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andreas M. Hohlbaum's work include T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Andreas M. Hohlbaum is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Andreas M. Hohlbaum collaborates with scholars based in United States, Germany and United Kingdom. Andreas M. Hohlbaum's co-authors include Ann Marshak‐Rothstein, Mark J. Shlomchik, Britte Beaudette-Zlatanova, Ian R. Rifkin, Elizabeth A. Leadbetter, S Moe, Shyr‐Te Ju, Meredith S. Gregory, Hendrik Gille and Arne Skerra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Andreas M. Hohlbaum

25 papers receiving 2.3k citations

Hit Papers

Chromatin–IgG complexes activate B cells by dual engageme... 2002 2026 2010 2018 2002 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
    2002 1.5k citations Elizabeth A. Leadbetter, Ian R. Rifkin et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas M. Hohlbaum United States 15 1.6k 644 407 293 193 25 2.4k
Marie‐Laure Santiago‐Raber Switzerland 26 1.5k 0.9× 475 0.7× 591 1.5× 212 0.7× 352 1.8× 46 2.1k
Florian Weisel United States 21 2.1k 1.3× 630 1.0× 214 0.5× 244 0.8× 246 1.3× 27 3.0k
Marc Ehlers Germany 23 1.3k 0.8× 551 0.9× 205 0.5× 391 1.3× 421 2.2× 49 2.0k
Ko Okumura Japan 29 1.6k 1.0× 901 1.4× 394 1.0× 403 1.4× 400 2.1× 70 2.8k
R. B. Nussenblatt United States 23 1.1k 0.7× 432 0.7× 493 1.2× 246 0.8× 300 1.6× 45 2.8k
Joachim R. Grün Germany 22 1.3k 0.8× 467 0.7× 312 0.8× 78 0.3× 282 1.5× 45 1.9k
Sean R. Christensen United States 16 2.9k 1.8× 392 0.6× 965 2.4× 299 1.0× 296 1.5× 34 3.3k
Markus Napirei Germany 18 1.4k 0.9× 889 1.4× 303 0.7× 103 0.4× 134 0.7× 28 2.3k
Jesús Merino Spain 24 1.1k 0.7× 780 1.2× 172 0.4× 141 0.5× 222 1.2× 73 2.1k
Marcin Okrój Poland 22 757 0.5× 394 0.6× 166 0.4× 153 0.5× 158 0.8× 62 1.4k

Countries citing papers authored by Andreas M. Hohlbaum

Since Specialization
Citations

This map shows the geographic impact of Andreas M. Hohlbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas M. Hohlbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas M. Hohlbaum more than expected).

Fields of papers citing papers by Andreas M. Hohlbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas M. Hohlbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas M. Hohlbaum. The network helps show where Andreas M. Hohlbaum may publish in the future.

Co-authorship network of co-authors of Andreas M. Hohlbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas M. Hohlbaum. A scholar is included among the top collaborators of Andreas M. Hohlbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas M. Hohlbaum. Andreas M. Hohlbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burdick, Andrew D., Annick Cauvin, Anthony M. DeLise, et al.. (2025). Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider. Regulatory Toxicology and Pharmacology. 158. 105793–105793. 1 indexed citations
2.
Matschiner, Gabriele, Mary Fitzgerald, Ulrich Moebius, et al.. (2022). Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma. Journal of Allergy and Clinical Immunology. 151(4). 966–975. 11 indexed citations
3.
Hohlbaum, Andreas M., Hendrik Gille, Stefan Trentmann, et al.. (2018). Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey. British Journal of Pharmacology. 175(7). 1054–1065. 28 indexed citations
4.
5.
Gille, Hendrik, Martin Hülsmeyer, Stefan Trentmann, et al.. (2015). Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class. Angiogenesis. 19(1). 79–94. 33 indexed citations
6.
7.
Meier, Reinhard, Rickmer Braren, Johanna Bussemer, et al.. (2014). Multimodality Multiparametric Imaging of Early Tumor Response to a Novel Antiangiogenic Therapy Based on Anticalins. PLoS ONE. 9(5). e94972–e94972. 14 indexed citations
8.
Olwill, Shane A., Hendrik Gille, Elisa Vigna, et al.. (2013). A Highly Potent and Specific MET Therapeutic Protein Antagonist with Both Ligand-Dependent and Ligand-Independent Activity. Molecular Cancer Therapeutics. 12(11). 2459–2471. 25 indexed citations
9.
Danov, Olga, Armin Braun, Christine Förster, et al.. (2013). IL-13-induced cytokine release and hyperresponsiveness in precision cut lung slices of different species - Characterization of a model potentially suitable for translational research of asthma cellular events. European Respiratory Journal. 42(Suppl 57). 5026–5026. 1 indexed citations
10.
Laarakkers, Coby M., Erwin T. Wiegerinck, Siem M. Klaver, et al.. (2013). Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform. PLoS ONE. 8(10). e75518–e75518. 71 indexed citations
11.
Gregory, Meredith S., Caroline G. Hackett, Karen Lee, et al.. (2011). Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death. PLoS ONE. 6(3). e17659–e17659. 76 indexed citations
12.
Schönfeld, D.L., Gabriele Matschiner, Lorenz Chatwell, et al.. (2009). An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. Proceedings of the National Academy of Sciences. 106(20). 8198–8203. 87 indexed citations
13.
Hohlbaum, Andreas M. & Arne Skerra. (2007). Anticalins®: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies. Expert Review of Clinical Immunology. 3(4). 491–501. 16 indexed citations
14.
Saff, Rebecca R., et al.. (2004). Activation-Induced Cell Death Limits Effector Function of CD4 Tumor-Specific T Cells. The Journal of Immunology. 172(11). 6598–6606. 20 indexed citations
15.
Leadbetter, Elizabeth A., Ian R. Rifkin, Andreas M. Hohlbaum, et al.. (2002). Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416(6881). 603–607. 1493 indexed citations breakdown →
16.
Hohlbaum, Andreas M., Rebecca R. Saff, & Ann Marshak‐Rothstein. (2002). Fas-Ligand—Iron Fist or Achilles' Heel?. Clinical Immunology. 103(1). 1–6. 12 indexed citations
17.
Hohlbaum, Andreas M., Meredith S. Gregory, Shyr‐Te Ju, & Ann Marshak‐Rothstein. (2001). Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors. The Journal of Immunology. 167(11). 6217–6224. 134 indexed citations
18.
Jodo, Satoshi, Sheng Xiao, Andreas M. Hohlbaum, et al.. (2001). Apoptosis-inducing Membrane Vesicles. Journal of Biological Chemistry. 276(43). 39938–39944. 52 indexed citations
19.
Jodo, Satoshi, Andreas M. Hohlbaum, Sheng Xiao, et al.. (2000). CD95 (Fas) Ligand-Expressing Vesicles Display Antibody-Mediated, FcR-Dependent Enhancement of Cytotoxicity. The Journal of Immunology. 165(10). 5487–5494. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Laure Santiago‐Raber Breakdown of academic impact, for papers by Florian Weisel Breakdown of academic impact, for papers by Marc Ehlers Breakdown of academic impact, for papers by Ko Okumura Breakdown of academic impact, for papers by R. B. Nussenblatt Breakdown of academic impact, for papers by Joachim R. Grün Breakdown of academic impact, for papers by Sean R. Christensen Breakdown of academic impact, for papers by Markus Napirei Breakdown of academic impact, for papers by Jesús Merino Breakdown of academic impact, for papers by Marcin Okrój
Rankless by CCL
2026